The Department of Drug Administration in Nepal has revoked the manufacturing and registration certificates of 47 immunosuppressant brands, citing concerns regarding drug quality and safety standards. This sweeping decision has sparked significant criticism from medical professionals, who fear the move could disrupt essential care for thousands of transplant recipients and patients with chronic illnesses.
Sign in with Google to open the full article.
The Department of Drug Administration in Nepal has revoked the manufacturing and registration certificates of 47 immunosuppressant brands, citing concerns regarding drug quality and safety standards. This sweeping decision has sparked significant criticism from medical professionals, who fear the move could disrupt essential care for thousands of transplant recipients and patients with chronic illnesses.
Constitutional law expert Bipin Adhikari manages a Twitter account that shares the late BP Koirala’s historic speeches and writings to provi…
The Nepal Premier League provides a crucial platform for emerging cricketers to gain professional experience and develop the tactical compos…
Less than 24 hours after its regular meeting on Tuesday, the Cabinet convened again on Wednesday and decided to remove Nepal Police Inspecto…
Democrats secured majorities in both the House and Senate after a wave of decisive victories across several traditional Republican stronghol…